InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Friday, 08/18/2017 5:26:14 AM

Friday, August 18, 2017 5:26:14 AM

Post# of 15799
OPKO Health initiated with an Overweight at Cantor Cantor Fitzgerald analyst Louise Chen started OPKO Health with an Overweight rating and $20 price target. The uptake of Rayaldee, commercialization of the company's branded drug pipeline, and BioReference sales growth should drive upward earnings revisions, Chen tells investors in a research note. The healthcare company closed yesterday down 18c to $5.88.

Read more at:
http://thefly.com/landingPageNews.php?id=2598214
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News